Tower Research Capital (TRC)’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Tower Research Capital (TRC)’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,972	Closed	-$1K	–	6671
2022 Q4	$1K	Buy	12,972 +9,422	+265%	+$6.01K	﹤0.01%	5796
2022 Q3	$4K	Buy	+3,550	New	+$8.09K	﹤0.01%	5334
2022 Q1	–	Sell	-169	Closed	-$1K	–	6935
2021 Q4	$1K	Buy	+169	New	+$1.07K	﹤0.01%	5994
2021 Q3	–	Sell	-4,402	Closed	-$30K	–	6404
2021 Q2	$30K	Buy	4,402 +3,118	+243%	+$19.7K	﹤0.01%	3506
2021 Q1	$16K	Buy	+1,284	New	+$25.5K	﹤0.01%	4077

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Tower Research Capital (TRC)'s LHDX Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 12,972 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in LHDX in Q1 2021 and held it in 5 quarters. The position peaked at $30K in Q2 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 12,972 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Tower Research Capital (TRC)'s Lucira Health, Inc. Common Stock position peaked at $30K in Q2 2021.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.